Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor

Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4110-4111. doi: 10.1007/s00259-023-06335-9. Epub 2023 Jul 15.
No abstract available

MeSH terms

  • Heterocyclic Compounds, 1-Ring
  • Humans
  • Neuroendocrine Tumors* / diagnostic imaging
  • Neuroendocrine Tumors* / pathology
  • Organometallic Compounds* / therapeutic use
  • Receptors, Somatostatin
  • Somatostatin

Substances

  • 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
  • Heterocyclic Compounds, 1-Ring
  • Somatostatin
  • Organometallic Compounds
  • Receptors, Somatostatin